# Cytomegalovirus Vaccine in Healthy Participants

> **NCT00712634** · PHASE1 · COMPLETED · sponsor: **City of Hope Medical Center** · enrollment: 46 (estimated)

## Conditions studied

- Precancerous/Nonmalignant Condition

## Interventions

- **BIOLOGICAL:** CMVpp65-A*0201 peptide vaccine

## Key facts

- **NCT ID:** NCT00712634
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-11
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2009-12-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00712634

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00712634, "Cytomegalovirus Vaccine in Healthy Participants". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00712634. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*